Author

Wei Gao

University of MichiganORCID 0000-0002-0522-7234Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Wei Gao2 papers · The University of Melbourne

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Bo WeniD· 1 shared Chengyi LiiD· 1 shared Duxin SuniD· 1 shared Hanning Wen· 1 shared Hongyi ZhaoiD· 1 shared Jinsong TaoiD· 1 shared Mahamadou Djibo· 1 shared Meilin WangiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Bo WenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintFeb 14, 2024

Dual Targeting of STING and PI3Kγ Eliminates Regulatory B Cells to Overcome STING Resistance for Pancreatic Cancer Immunotherapy

Chengyi Li, Shuai Mao, Hongyi Zhao…·Duxin Sun

This paper develops a dual-targeting compound that eliminates regulatory B cells and overcomes STING resistance in pancreatic cancer, improving immunotherapy outcomes.

DOI 10.1101/2024.02.14.580378

mouseproteomics

𝕏 PostBluesky